{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:35:55Z","timestamp":1791228955595,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute for Deafness and Communication Disorders","award":["NIDCD R01DC017144"],"award-info":[{"award-number":["NIDCD R01DC017144"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A mouse model with cisplatin-induced ototoxicity was used in addition to human samples from the ITMAT Biobank at the University of Pennsylvania. Mouse auditory brainstem responses (ABR), inner ear histology, perilymph cisplatin sampling, and measurement of serum prestin via ELISA were performed. Human serum prestin level was measured via ELISA in patients with otological issues after cisplatin treatment and compared to matched controls. Serum prestin was significantly elevated before ABR threshold shifts in mice exposed to cisplatin compared to control mice. Prestin concentration also correlated with the severity of hearing threshold shifts in mice. After an extended rest post-cisplatin treatment, prestin returned to baseline levels in mice and humans. Prestin was significantly elevated in the serum before the onset of objective hearing loss and correlated with the severity of hearing damage indicating that prestin may function as an effective biomarker of cisplatin-induced ototoxicity. Human serum prestin levels responded similarly to mice\u2009&gt;\u20093\u00a0weeks from ototoxic exposure with decreased levels of prestin in the serum.<\/jats:p>","DOI":"10.1038\/s41598-022-23034-x","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T10:03:55Z","timestamp":1666865035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Subclinical diagnosis of cisplatin-induced ototoxicity with biomarkers"],"prefix":"10.1038","volume":"12","author":[{"given":"Charles","family":"Generotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon C.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarnail","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Bert W.","family":"O\u2019Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"issue":"5","key":"23034_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1177\/000992286700600505","volume":"6","author":"HJ Meuwissen","year":"1967","unstructured":"Meuwissen, H. J., Phil, B. & Robinson, G. C. Therapeutic review: The ototoxic antibiotics: A survey of current knowledge. Clin. Pediatr. 6(5), 262\u2013269 (1967).","journal-title":"Clin. Pediatr."},{"key":"23034_CR2","first-page":"2017","volume-title":"WHO Model List of Essential Medicines, 20th List (March 2017, Amended August 2017)","author":"World Health O","year":"2017","unstructured":"World Health O. WHO Model List of Essential Medicines, 20th List (March 2017, Amended August 2017) 2017 (World Health Organization, 2017)."},{"issue":"6","key":"23034_CR3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/archotol.1993.01880180081015","volume":"119","author":"SA Fausti","year":"1993","unstructured":"Fausti, S. A. et al. High-frequency monitoring for early detection of cisplatin ototoxicity. Arch. Otolaryngol. Head Neck Surg. 119(6), 661\u2013666 (1993).","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"6","key":"23034_CR4","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1200\/JCO.2006.10.077","volume":"24","author":"JM Rademaker-Lakhai","year":"2006","unstructured":"Rademaker-Lakhai, J. M. et al. Relationship between cisplatin administration and the development of ototoxicity. J. Clin. Oncol. 24(6), 918\u2013924 (2006).","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"23034_CR5","first-page":"268","volume":"3","author":"A Callejo","year":"2015","unstructured":"Callejo, A., Sed\u00f3-Cabez\u00f3n, L., Juan, I. & Llorens, J. Cisplatin-induced ototoxicity: Effects. Mech. Protect. Strateg. Toxics. 3(3), 268\u2013293 (2015).","journal-title":"Mech. Protect. Strateg. Toxics."},{"issue":"34","key":"23034_CR6","doi-asserted-by":"publisher","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","volume":"23","author":"KR Knight","year":"2005","unstructured":"Knight, K. R., Kraemer, D. F. & Neuwelt, E. A. Ototoxicity in children receiving platinum chemotherapy: Underestimating a commonly occurring toxicity that may influence academic and social development. J. Clin. Oncol. 23(34), 8588\u20138596 (2005).","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"23034_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/sj.bmt.1701391","volume":"22","author":"S Parsons","year":"1998","unstructured":"Parsons, S. et al. Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma. Bone Marrow Transplant. 22(7), 669\u2013674 (1998).","journal-title":"Bone Marrow Transplant."},{"issue":"10","key":"23034_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/01.mph.0000141348.62532.73","volume":"26","author":"P Bertolini","year":"2004","unstructured":"Bertolini, P. et al. Platinum compound-related ototoxicity in children: Long-term follow-up reveals continuous worsening of hearing loss. J. Pediatr. Hematol. Oncol. 26(10), 649\u2013655 (2004).","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"3","key":"23034_CR9","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/pbc.24236","volume":"60","author":"AL Abujamra","year":"2013","unstructured":"Abujamra, A. L. et al. The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy. Pediatr. Blood Cancer 60(3), 474\u2013478 (2013).","journal-title":"Pediatr. Blood Cancer"},{"issue":"2","key":"23034_CR10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.mehy.2015.04.015","volume":"85","author":"K Parham","year":"2015","unstructured":"Parham, K. Prestin as a biochemical marker for early detection of acquired sensorineural hearing loss. Med. Hypotheses 85(2), 130\u2013133 (2015).","journal-title":"Med. Hypotheses"},{"issue":"9","key":"23034_CR11","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1097\/MAO.0000000000001164","volume":"37","author":"K Parham","year":"2016","unstructured":"Parham, K. & Dyhrfjeld-Johnsen, J. Outer hair cell molecular protein, prestin, as a serum biomarker for hearing loss: Proof of concept. Otol. Neurotol. 37(9), 1217\u20131222 (2016).","journal-title":"Otol. Neurotol."},{"issue":"3","key":"23034_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1177\/0194599817742093","volume":"158","author":"J Naples","year":"2018","unstructured":"Naples, J., Cox, R., Bonaiuto, G. & Parham, K. Prestin as an otologic biomarker of cisplatin ototoxicity in a Guinea pig model. Otolaryngol. Head Neck Surg. 158(3), 541\u2013546 (2018).","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"8","key":"23034_CR13","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1177\/0145561319849949","volume":"99","author":"C Sun","year":"2020","unstructured":"Sun, C., Xuan, X., Zhou, Z., Yuan, Y. & Xue, F. A preliminary report on the investigation of prestin as a biomarker for idiopathic sudden sensorineural hearing loss. Ear Nose Throat J. 99(8), 528\u2013531 (2020).","journal-title":"Ear Nose Throat J."},{"key":"23034_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.heares.2018.11.013","volume":"371","author":"K Parham","year":"2019","unstructured":"Parham, K. et al. Noise-induced trauma produces a temporal pattern of change in blood levels of the outer hair cell biomarker prestin. Hear. Res. 371, 98\u2013104 (2019).","journal-title":"Hear. Res."},{"issue":"10","key":"23034_CR15","doi-asserted-by":"publisher","first-page":"e501","DOI":"10.1097\/MAO.0000000000001616","volume":"38","author":"B Liba","year":"2017","unstructured":"Liba, B. et al. Changes in serum prestin concentration after exposure to cisplatin. Otol. Neurotol. 38(10), e501\u2013e505 (2017).","journal-title":"Otol. Neurotol."},{"key":"23034_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.heares.2019.02.006","volume":"375","author":"K Fernandez","year":"2019","unstructured":"Fernandez, K., Wafa, T., Fitzgerald, T. S. & Cunningham, L. L. An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity. Hear. Res. 375, 66\u201374 (2019).","journal-title":"Hear. Res."},{"key":"23034_CR17","first-page":"e53561","volume":"107","author":"SC Montgomery","year":"2016","unstructured":"Montgomery, S. C. & Cox, B. C. Whole mount dissection and immunofluorescence of the adult mouse cochlea. J. Vis. Exp. 107, e53561 (2016).","journal-title":"J. Vis. Exp."},{"issue":"2","key":"23034_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","volume":"1","author":"R Mayeux","year":"2004","unstructured":"Mayeux, R. Biomarkers: Potential uses and limitations. NeuroRx 1(2), 182\u2013188 (2004).","journal-title":"NeuroRx"},{"issue":"5","key":"23034_CR19","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.amjoto.2018.07.007","volume":"39","author":"M Dogan","year":"2018","unstructured":"Dogan, M., Sahin, M., Cetin, N., Yilmaz, M. & Demirci, B. Utilizing prestin as a predictive marker for the early detection of outer hair cell damage. Am. J. Otolaryngol. 39(5), 594\u2013598 (2018).","journal-title":"Am. J. Otolaryngol."},{"issue":"1","key":"23034_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-01837-1","volume":"8","author":"AM Breglio","year":"2017","unstructured":"Breglio, A. M. et al. Cisplatin is retained in the cochlea indefinitely following chemotherapy. Nat. Commun. 8(1), 1\u201319 (2017).","journal-title":"Nat. Commun."},{"key":"23034_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.heares.2017.12.010","volume":"362","author":"AN Salt","year":"2018","unstructured":"Salt, A. N. & Hirose, K. Communication pathways to and from the inner ear and their contributions to drug delivery. Hear. Res. 362, 25\u201337 (2018).","journal-title":"Hear. Res."},{"issue":"1","key":"23034_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.heares.2006.08.011","volume":"222","author":"G-D Chen","year":"2006","unstructured":"Chen, G.-D. Prestin gene expression in the rat cochlea following intense noise exposure. Hear. Res. 222(1), 54\u201361 (2006).","journal-title":"Hear. Res."},{"issue":"12","key":"23034_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082602","volume":"8","author":"A Xia","year":"2013","unstructured":"Xia, A. et al. Prestin regulation and function in residual outer hair cells after noise-induced hearing loss. PLoS ONE 8(12), e82602 (2013).","journal-title":"PLoS ONE"},{"issue":"15","key":"23034_CR24","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1007\/s00018-008-8195-y","volume":"65","author":"N Yu","year":"2008","unstructured":"Yu, N. et al. Prestin up-regulation in chronic salicylate (aspirin) administration: An implication of functional dependence of prestin expression. Cell. Mol. Life Sci. 65(15), 2407\u20132418 (2008).","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"23034_CR25","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41598-022-05131-z","volume":"12","author":"A Parker","year":"2022","unstructured":"Parker, A., Parham, K. & Skoe, E. Noise exposure levels predict blood levels of the inner ear protein prestin. Sci. Rep. 12(1), 1154 (2022).","journal-title":"Sci. Rep."},{"issue":"5","key":"23034_CR26","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/AUD.0000000000001026","volume":"42","author":"A Parker","year":"2021","unstructured":"Parker, A., Parham, K. & Skoe, E. Reliability of serological prestin levels in humans and its relation to otoacoustic emissions, a functional measure of outer hair cells. Ear Hear. 42(5), 1151\u20131162 (2021).","journal-title":"Ear Hear."},{"key":"23034_CR27","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1007\/s00405-021-06967-3","volume":"279","author":"MM Jalali","year":"2021","unstructured":"Jalali, M. M., Saedi, H. S. & Saadat, F. Effect of cisplatin chemotherapy on the inner ear function and serum prestin concentration. Eur. Arch. Oto-Rhino Laryngol. 279, 2783\u20132789 (2021).","journal-title":"Eur. Arch. Oto-Rhino Laryngol."},{"issue":"1","key":"23034_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1227\/00006123-199507000-00003","volume":"37","author":"PC Williams","year":"1995","unstructured":"Williams, P. C. et al. Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms. Neurosurgery 37(1), 17\u201328 (1995).","journal-title":"Neurosurgery"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23034-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23034-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23034-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T17:17:19Z","timestamp":1701278239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23034-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["23034"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-23034-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]},"assertion":[{"value":"20 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18032"}}